198 related articles for article (PubMed ID: 12780752)
1. Hypothalamic growth hormone-releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader-Willi syndrome or obesity.
Goldstone AP; Unmehopa UA; Swaab DF
Clin Endocrinol (Oxf); 2003 Jun; 58(6):743-55. PubMed ID: 12780752
[TBL] [Abstract][Full Text] [Related]
2. Reduced growth hormone (GH) responsiveness to combined GH-releasing hormone and pyridostigmine administration in the Prader-Willi syndrome.
Grugni G; Guzzaloni G; Moro D; Bettio D; De Medici C; Morabito F
Clin Endocrinol (Oxf); 1998 Jun; 48(6):769-75. PubMed ID: 9713567
[TBL] [Abstract][Full Text] [Related]
3. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome.
Grugni G; Marzullo P; Ragusa L; Sartorio A; Trifirò G; Liuzzi A; Crinò A;
Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242
[TBL] [Abstract][Full Text] [Related]
4. GHRH plus arginine and arginine administration evokes the same ratio of GH isoforms levels in young patients with Prader-Willi syndrome.
Rigamonti AE; Crinò A; Bocchini S; Convertino A; Bidlingmaier M; Haenelt M; Tamini S; Cella SG; Grugni G; Sartorio A
Growth Horm IGF Res; 2018 Apr; 39():13-18. PubMed ID: 29217318
[TBL] [Abstract][Full Text] [Related]
5. Unaltered ratio of circulating levels of growth hormone/GH isoforms in adults with Prader-Willi syndrome after GHRH plus arginine administration.
Rigamonti AE; Grugni G; Marazzi N; Bini S; Bidlingmaier M; Sartorio A
Growth Horm IGF Res; 2015 Aug; 25(4):168-73. PubMed ID: 26059749
[TBL] [Abstract][Full Text] [Related]
6. The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.
Marostica E; Grugni G; De Nicolao G; Marazzi N; Crinò A; Cappa M; Sartorio A
Growth Horm IGF Res; 2013 Dec; 23(6):261-6. PubMed ID: 24090687
[TBL] [Abstract][Full Text] [Related]
7. GH/IGF-I axis in Prader-Willi syndrome: evaluation of IGF-I levels and of the somatotroph responsiveness to various provocative stimuli. Genetic Obesity Study Group of Italian Society of Pediatric Endocrinology and Diabetology.
Corrias A; Bellone J; Beccaria L; Bosio L; Trifirò G; Livieri C; Ragusa L; Salvatoni A; Andreo M; Ciampalini P; Tonini G; Crinò A
J Endocrinol Invest; 2000 Feb; 23(2):84-9. PubMed ID: 10800760
[TBL] [Abstract][Full Text] [Related]
8. Deconvolution-based assessment of pituitary GH secretion stimulated with GHRH+arginine in Prader-Willi adults and obese controls.
Grugni G; Marostica E; Crinò A; Marzullo P; De Nicolao G; Sartorio A
Clin Endocrinol (Oxf); 2013 Aug; 79(2):224-31. PubMed ID: 23301953
[TBL] [Abstract][Full Text] [Related]
9. Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.
Grugni G; Guzzaloni G; Morabito F
J Endocrinol Invest; 2001 May; 24(5):340-8. PubMed ID: 11407654
[TBL] [Abstract][Full Text] [Related]
10. Stimulated GH levels during the transition phase in Prader-Willi syndrome.
Grugni G; Marzullo P; Delvecchio M; Iughetti L; Licenziati MR; Osimani S; Ragusa L; Salvatoni A; Sartorio A; Stagi S; Crinò A;
J Endocrinol Invest; 2021 Jul; 44(7):1465-1474. PubMed ID: 33095904
[TBL] [Abstract][Full Text] [Related]
11. The growth hormone response to hexarelin in patients with Prader-Willi syndrome.
Cappa M; Raguso G; Palmiotto T; Faedda A; Gurreri F; Neri G; Deghenghi R; Loche S
J Endocrinol Invest; 1998 Sep; 21(8):501-5. PubMed ID: 9801990
[TBL] [Abstract][Full Text] [Related]
12. Hypothalamic NPY and agouti-related protein are increased in human illness but not in Prader-Willi syndrome and other obese subjects.
Goldstone AP; Unmehopa UA; Bloom SR; Swaab DF
J Clin Endocrinol Metab; 2002 Feb; 87(2):927-37. PubMed ID: 11836343
[TBL] [Abstract][Full Text] [Related]
13. Body fat excess and stimulated growth hormone levels in adult patients with Prader-Willi syndrome.
Grugni G; Crinò A; Bertocco P; Marzullo P
Am J Med Genet A; 2009 Feb; 149A(4):726-31. PubMed ID: 19267411
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone secretion and effects of growth hormone therapy on growth velocity and weight gain in children with Prader-Willi syndrome.
Angulo M; Castro-Magana M; Mazur B; Canas JA; Vitollo PM; Sarrantonio M
J Pediatr Endocrinol Metab; 1996; 9(3):393-400. PubMed ID: 8887149
[TBL] [Abstract][Full Text] [Related]
15. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.
Fronczek R; Lammers GJ; Balesar R; Unmehopa UA; Swaab DF
J Clin Endocrinol Metab; 2005 Sep; 90(9):5466-70. PubMed ID: 15985489
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome.
Donze SH; Damen L; van Alfen-van der Velden JAEM; Bocca G; Finken MJJ; Hoorweg-Nijman GJG; Jira PE; van Leeuwen M; Hokken-Koelega ACS
Clin Endocrinol (Oxf); 2019 Jul; 91(1):118-123. PubMed ID: 30973645
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone secretory pattern in non-obese children and adolescents with Prader-Willi syndrome.
Grugni G; Crinò A; Pagani S; Meazza C; Buzi F; De Toni T; Gargantini L; Pilotta A; Pozzan GB; Radetti G; Ragusa L; Salvatoni A; Sartorio A; Bozzola M;
J Pediatr Endocrinol Metab; 2011; 24(7-8):477-81. PubMed ID: 21932585
[TBL] [Abstract][Full Text] [Related]
18. Correlation of adiponectin receptor expression with cytokines and insulin sensitivity in growth hormone (GH)-treated children with Prader-Willi syndrome and in non-GH-treated obese children.
Sohn YB; Kwak MJ; Kim SJ; Park SW; Kim CH; Kim MY; Kwon EK; Paik KH; Jin DK
J Clin Endocrinol Metab; 2010 Mar; 95(3):1371-7. PubMed ID: 20061428
[TBL] [Abstract][Full Text] [Related]
19. Serum adiponectin levels in adults with Prader-Willi syndrome are independent of anthropometrical parameters and do not change with GH treatment.
Hoybye C; Bruun JM; Richelsen B; Flyvbjerg A; Frystyk J
Eur J Endocrinol; 2004 Oct; 151(4):457-61. PubMed ID: 15476445
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.
Bakker NE; van Doorn J; Renes JS; Donker GH; Hokken-Koelega AC
J Clin Endocrinol Metab; 2015 Aug; 100(8):3041-9. PubMed ID: 26050733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
